Linked Data API

Show Search Form

Search Results

100180
star this property registered interest false more like this
star this property date less than 2014-10-21more like thismore than 2014-10-21
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading NHS England more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, how many meetings the Parliamentary Under-Secretary of State for Public Health has had with James Palmer, Clinical Director for Specialised Commissioning at NHS England since 1 April 2014. more like this
star this property tabling member constituency Wells more like this
star this property tabling member printed
Tessa Munt remove filter
star this property uin 211213 more like this
star this property answer
answer
star this property is ministerial correction false remove filter
star this property date of answer less than 2014-10-28more like thismore than 2014-10-28
star this property answer text <p>I have had no meetings with James Palmer, Clinical Director for Specialised Commissioning at NHS England since 1 April 2014.</p><p> </p><p><strong> </strong></p><p> </p><p>There is regular contact between Departmental officials and Clinical Directors at NHS England, including the Clinical Director for Specialised Commissioning.</p><p> </p><p><strong> </strong></p><p> </p> more like this
star this property answering member constituency Battersea more like this
unstar this property answering member printed Jane Ellison remove filter
star this property question first answered
less than 2014-10-28T17:45:28.5017361Zmore like thismore than 2014-10-28T17:45:28.5017361Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4089
star this property label Biography information for Tessa Munt more like this
100196
star this property registered interest false more like this
star this property date less than 2014-10-21more like thismore than 2014-10-21
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Radiotherapy more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, whether the signature authorising Individual Funding Requests made to NHS England for Gamma Knife treatment by University College Hospital London, Queen Square, is that of a senior clinician employed by University College Hospital London. more like this
star this property tabling member constituency Wells more like this
star this property tabling member printed
Tessa Munt remove filter
star this property uin 211310 more like this
star this property answer
answer
star this property is ministerial correction false remove filter
star this property date of answer less than 2014-10-27more like thismore than 2014-10-27
star this property answer text <p>We are advised by NHS England that the clinician who authorises Individual Funding Requests for Gamma Knife treatment to be undertaken at the Queens Square Radiology Centre Ltd (QSRC) is a surgeon at the National Hospital for Neurosurgery and Neurology (NHNN), part of University College London Hospitals NHS Foundation Trust (UCLH).</p><p> </p><p> </p><p> </p><p>Gamma Knife treatment is not undertaken by UCLH but by the private company QSRC, which is based at NHNN but has no formal relationship with UCLH.</p><p> </p><p><strong> </strong></p><p> </p> more like this
star this property answering member constituency Battersea more like this
unstar this property answering member printed Jane Ellison remove filter
star this property question first answered
less than 2014-10-27T16:54:23.3483501Zmore like thismore than 2014-10-27T16:54:23.3483501Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4089
star this property label Biography information for Tessa Munt more like this
102048
star this property registered interest false more like this
star this property date less than 2014-10-31more like thismore than 2014-10-31
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Radiotherapy more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, with reference to the Answer of 22 October 2013, to Question 171517, for what reasons NHS England's review into stereotactic radiosurgery was not completed by the end of 2013; and when NHS England will complete this review. more like this
star this property tabling member constituency Wells more like this
star this property tabling member printed
Tessa Munt remove filter
star this property uin 212823 more like this
star this property answer
answer
star this property is ministerial correction false remove filter
star this property date of answer less than 2014-11-07more like thismore than 2014-11-07
star this property answer text <p>NHS England released ‘Stereotactic Radiosurgery and Radiotherapy Services – needs assessment and service review’ on 3 November. NHS England is now consulting on this document until 26 January 2015, after which it will publish a report outlining the key themes of the consultation findings on its website.</p><p> </p><p> </p><p> </p><p>NHS England advises us that the review took more time than originally planned to ensure that the options being consulted on were as comprehensive as possible. This included further testing of a number of issues including the appropriate level of throughput activity in each centre.</p><p> </p><p> </p><p> </p> more like this
star this property answering member constituency Battersea more like this
unstar this property answering member printed Jane Ellison remove filter
star this property question first answered
less than 2014-11-07T13:36:47.1405961Zmore like thismore than 2014-11-07T13:36:47.1405961Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4089
star this property label Biography information for Tessa Munt more like this
102052
star this property registered interest false more like this
star this property date less than 2014-10-31more like thismore than 2014-10-31
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading University College Hospital more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, whether University College Hospital London included the provision of gamma knife services at its Queen Square site in its notification log to commissioners before 1 April 2013. more like this
star this property tabling member constituency Wells more like this
star this property tabling member printed
Tessa Munt remove filter
star this property uin 212820 more like this
star this property answer
answer
star this property is ministerial correction false remove filter
star this property date of answer less than 2014-11-07more like thismore than 2014-11-07
star this property answer text <p>The Consolidated Notification Log 2012/13 record dated 30 September 2011 makes reference to a gamma knife service that might be available sometime in the future at the National Hospital for Neurology and Neurosurgery, part of University College London Hospitals NHS Foundation Trust (UCLH). A gamma knife service is not currently provided by the Trust.</p><p> </p><p> </p><p> </p><p>A gamma knife service is provided by an independent provider called Queen’s Square Radiotherapy Centre Limited based at Queen’s Square (a site owned by UCLH).</p><p> </p> more like this
star this property answering member constituency Battersea more like this
unstar this property answering member printed Jane Ellison remove filter
star this property question first answered
less than 2014-11-07T13:35:45.6662222Zmore like thismore than 2014-11-07T13:35:45.6662222Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4089
star this property label Biography information for Tessa Munt more like this
106319
star this property registered interest false more like this
star this property date less than 2014-11-04more like thismore than 2014-11-04
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Radiotherapy more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, whether NHS England's Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review published in November 2014 is solely for the purpose of assessing the needs of intracranial radiotherapy treatment in England. more like this
star this property tabling member constituency Wells more like this
star this property tabling member printed
Tessa Munt remove filter
star this property uin 213359 more like this
star this property answer
answer
star this property is ministerial correction false remove filter
star this property date of answer less than 2014-11-07more like thismore than 2014-11-07
star this property answer text <p>NHS England’s review is concerned with assessing and meeting the need for the treatment of intracranial conditions with SRS/SRT; fractionated extracranial radiotherapy and Stereotactic Ablative Radiotherapy (SABR) are not included in the review.</p><p> </p><p><strong> </strong></p><p> </p><p>The two activity scenarios in the consultation document assume a significant growth in treatment rates. Scenario A is based on the level of need identified in the NHS England Clinical Commissioning Policies, whilst scenario B is based on an expected growth demand based on the treatment rates of some other European countries. The relative merits of these two scenarios are laid out from page eight of the consultation document</p><p> </p><p> </p><p> </p><p>www.engage.england.nhs.uk/survey/options-for-change/supporting_documents/srssrtconsultguide021114.pdf</p><p> </p><p> </p><p> </p><p>NHS England’s reasons for recommending scenario A with a seven-day working week, ‘Option 2’, is set out in their report as follows:</p><p> </p><p> </p><p> </p><p>“SCOG [the Specialised Commissioning Oversight Group] decided on Option 2 as the preferred option as it is based on seven-day working, which aligns to the national strategic direction of moving towards seven-day service provision. Additionally, the risk of overcapacity is minimised if clinical trends change more slowly than expected because the centres providing the service could revert to fewer days per week. The avoidance of machines lying idle 2/7ths of the week will ensure best price for the NHS. Option 2 could be superseded by further expansion of national capacity should the activity levels increase beyond those described in Scenario A.”</p><p> </p><p> </p><p> </p><p>“It was recognised that in planning for Option 2, future increases in capacity would still be possible should activity levels rise beyond those described in Scenario A, in order to mitigate any risk of future under-capacity”</p><p> </p><p> </p><p> </p><p>The national recommendation that a minimum number patients be treated each year relates specifically to Stereotactic Ablative Radiotherapy (SABR) which is out of the scope of this consultation.</p><p> </p><p> </p><p> </p><p>NHS England's Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review is currently subject to an ongoing public consultation, which closes on 26 January 2015. NHS England would welcome any detailed comments being fed directly into the consultation process, including on data sources. Comments can be made at this link:</p><p> </p><p> </p><p>www.engage.england.nhs.uk/survey/options-for-change</p>
star this property answering member constituency Battersea more like this
unstar this property answering member printed Jane Ellison remove filter
star this property grouped question UIN
213360 more like this
213361 more like this
213362 more like this
star this property question first answered
less than 2014-11-07T13:57:03.901265Zmore like thismore than 2014-11-07T13:57:03.901265Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4089
star this property label Biography information for Tessa Munt more like this
106320
star this property registered interest false more like this
star this property date less than 2014-11-04more like thismore than 2014-11-04
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Brain: Tumours more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, with reference to NHS England's Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review published in November 2014, what evidence NHS England has received that demonstrates that instances of both malignant and benign brain tumours are lower in England than in other devoloped countries; and for what reasons NHS England is supporting proposals which will prevent the NHS from adopting a programme to allow it to reach parity with other developed countries for the provision of stereotactic radiotherapy for brain tumours. more like this
star this property tabling member constituency Wells more like this
star this property tabling member printed
Tessa Munt remove filter
star this property uin 213360 more like this
star this property answer
answer
star this property is ministerial correction false remove filter
star this property date of answer less than 2014-11-07more like thismore than 2014-11-07
star this property answer text <p>NHS England’s review is concerned with assessing and meeting the need for the treatment of intracranial conditions with SRS/SRT; fractionated extracranial radiotherapy and Stereotactic Ablative Radiotherapy (SABR) are not included in the review.</p><p> </p><p><strong> </strong></p><p> </p><p>The two activity scenarios in the consultation document assume a significant growth in treatment rates. Scenario A is based on the level of need identified in the NHS England Clinical Commissioning Policies, whilst scenario B is based on an expected growth demand based on the treatment rates of some other European countries. The relative merits of these two scenarios are laid out from page eight of the consultation document</p><p> </p><p> </p><p> </p><p>www.engage.england.nhs.uk/survey/options-for-change/supporting_documents/srssrtconsultguide021114.pdf</p><p> </p><p> </p><p> </p><p>NHS England’s reasons for recommending scenario A with a seven-day working week, ‘Option 2’, is set out in their report as follows:</p><p> </p><p> </p><p> </p><p>“SCOG [the Specialised Commissioning Oversight Group] decided on Option 2 as the preferred option as it is based on seven-day working, which aligns to the national strategic direction of moving towards seven-day service provision. Additionally, the risk of overcapacity is minimised if clinical trends change more slowly than expected because the centres providing the service could revert to fewer days per week. The avoidance of machines lying idle 2/7ths of the week will ensure best price for the NHS. Option 2 could be superseded by further expansion of national capacity should the activity levels increase beyond those described in Scenario A.”</p><p> </p><p> </p><p> </p><p>“It was recognised that in planning for Option 2, future increases in capacity would still be possible should activity levels rise beyond those described in Scenario A, in order to mitigate any risk of future under-capacity”</p><p> </p><p> </p><p> </p><p>The national recommendation that a minimum number patients be treated each year relates specifically to Stereotactic Ablative Radiotherapy (SABR) which is out of the scope of this consultation.</p><p> </p><p> </p><p> </p><p>NHS England's Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review is currently subject to an ongoing public consultation, which closes on 26 January 2015. NHS England would welcome any detailed comments being fed directly into the consultation process, including on data sources. Comments can be made at this link:</p><p> </p><p> </p><p>www.engage.england.nhs.uk/survey/options-for-change</p>
star this property answering member constituency Battersea more like this
unstar this property answering member printed Jane Ellison remove filter
star this property grouped question UIN
213359 more like this
213361 more like this
213362 more like this
star this property question first answered
less than 2014-11-07T13:57:04.1669429Zmore like thismore than 2014-11-07T13:57:04.1669429Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4089
star this property label Biography information for Tessa Munt more like this
106321
star this property registered interest false more like this
star this property date less than 2014-11-04more like thismore than 2014-11-04
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Radiotherapy more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, with reference to NHS England's Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review published in November 2014, section 58, how NHS England is able accurately to protect the growth requirements for stereotactic radiosurgery if the data source it is using does not allow it to draw firm conclusions for the purposes of this Review. more like this
star this property tabling member constituency Wells more like this
star this property tabling member printed
Tessa Munt remove filter
star this property uin 213361 more like this
star this property answer
answer
star this property is ministerial correction false remove filter
star this property date of answer less than 2014-11-07more like thismore than 2014-11-07
star this property answer text <p>NHS England’s review is concerned with assessing and meeting the need for the treatment of intracranial conditions with SRS/SRT; fractionated extracranial radiotherapy and Stereotactic Ablative Radiotherapy (SABR) are not included in the review.</p><p> </p><p><strong> </strong></p><p> </p><p>The two activity scenarios in the consultation document assume a significant growth in treatment rates. Scenario A is based on the level of need identified in the NHS England Clinical Commissioning Policies, whilst scenario B is based on an expected growth demand based on the treatment rates of some other European countries. The relative merits of these two scenarios are laid out from page eight of the consultation document</p><p> </p><p> </p><p> </p><p>www.engage.england.nhs.uk/survey/options-for-change/supporting_documents/srssrtconsultguide021114.pdf</p><p> </p><p> </p><p> </p><p>NHS England’s reasons for recommending scenario A with a seven-day working week, ‘Option 2’, is set out in their report as follows:</p><p> </p><p> </p><p> </p><p>“SCOG [the Specialised Commissioning Oversight Group] decided on Option 2 as the preferred option as it is based on seven-day working, which aligns to the national strategic direction of moving towards seven-day service provision. Additionally, the risk of overcapacity is minimised if clinical trends change more slowly than expected because the centres providing the service could revert to fewer days per week. The avoidance of machines lying idle 2/7ths of the week will ensure best price for the NHS. Option 2 could be superseded by further expansion of national capacity should the activity levels increase beyond those described in Scenario A.”</p><p> </p><p> </p><p> </p><p>“It was recognised that in planning for Option 2, future increases in capacity would still be possible should activity levels rise beyond those described in Scenario A, in order to mitigate any risk of future under-capacity”</p><p> </p><p> </p><p> </p><p>The national recommendation that a minimum number patients be treated each year relates specifically to Stereotactic Ablative Radiotherapy (SABR) which is out of the scope of this consultation.</p><p> </p><p> </p><p> </p><p>NHS England's Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review is currently subject to an ongoing public consultation, which closes on 26 January 2015. NHS England would welcome any detailed comments being fed directly into the consultation process, including on data sources. Comments can be made at this link:</p><p> </p><p> </p><p>www.engage.england.nhs.uk/survey/options-for-change</p>
star this property answering member constituency Battersea more like this
unstar this property answering member printed Jane Ellison remove filter
star this property grouped question UIN
213359 more like this
213360 more like this
213362 more like this
star this property question first answered
less than 2014-11-07T13:57:04.3075314Zmore like thismore than 2014-11-07T13:57:04.3075314Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4089
star this property label Biography information for Tessa Munt more like this
106322
star this property registered interest false more like this
star this property date less than 2014-11-04more like thismore than 2014-11-04
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Radiotherapy more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, with reference to NHS England's Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review published in November 2014, section 96, if he will ensure that NHS England's proposals to use modified Linacs to supplement highly specialised stereotactic radiotherapy provision (a) comply with national recommendations that a minimum number of 25 patients is treated each year and (b) do not reduce patient access to the conventional radiotherapy the Linacs are designed to provide. more like this
star this property tabling member constituency Wells more like this
star this property tabling member printed
Tessa Munt remove filter
star this property uin 213362 more like this
star this property answer
answer
star this property is ministerial correction false remove filter
star this property date of answer less than 2014-11-07more like thismore than 2014-11-07
star this property answer text <p>NHS England’s review is concerned with assessing and meeting the need for the treatment of intracranial conditions with SRS/SRT; fractionated extracranial radiotherapy and Stereotactic Ablative Radiotherapy (SABR) are not included in the review.</p><p> </p><p><strong> </strong></p><p> </p><p>The two activity scenarios in the consultation document assume a significant growth in treatment rates. Scenario A is based on the level of need identified in the NHS England Clinical Commissioning Policies, whilst scenario B is based on an expected growth demand based on the treatment rates of some other European countries. The relative merits of these two scenarios are laid out from page eight of the consultation document</p><p> </p><p> </p><p> </p><p>www.engage.england.nhs.uk/survey/options-for-change/supporting_documents/srssrtconsultguide021114.pdf</p><p> </p><p> </p><p> </p><p>NHS England’s reasons for recommending scenario A with a seven-day working week, ‘Option 2’, is set out in their report as follows:</p><p> </p><p> </p><p> </p><p>“SCOG [the Specialised Commissioning Oversight Group] decided on Option 2 as the preferred option as it is based on seven-day working, which aligns to the national strategic direction of moving towards seven-day service provision. Additionally, the risk of overcapacity is minimised if clinical trends change more slowly than expected because the centres providing the service could revert to fewer days per week. The avoidance of machines lying idle 2/7ths of the week will ensure best price for the NHS. Option 2 could be superseded by further expansion of national capacity should the activity levels increase beyond those described in Scenario A.”</p><p> </p><p> </p><p> </p><p>“It was recognised that in planning for Option 2, future increases in capacity would still be possible should activity levels rise beyond those described in Scenario A, in order to mitigate any risk of future under-capacity”</p><p> </p><p> </p><p> </p><p>The national recommendation that a minimum number patients be treated each year relates specifically to Stereotactic Ablative Radiotherapy (SABR) which is out of the scope of this consultation.</p><p> </p><p> </p><p> </p><p>NHS England's Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review is currently subject to an ongoing public consultation, which closes on 26 January 2015. NHS England would welcome any detailed comments being fed directly into the consultation process, including on data sources. Comments can be made at this link:</p><p> </p><p> </p><p>www.engage.england.nhs.uk/survey/options-for-change</p>
star this property answering member constituency Battersea more like this
unstar this property answering member printed Jane Ellison remove filter
star this property grouped question UIN
213359 more like this
213360 more like this
213361 more like this
star this property question first answered
less than 2014-11-07T13:57:04.402797Zmore like thismore than 2014-11-07T13:57:04.402797Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4089
star this property label Biography information for Tessa Munt more like this
114825
star this property registered interest false more like this
star this property date less than 2014-11-05more like thismore than 2014-11-05
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Radiotherapy more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, with reference to sections 105 and 120 of NHS England's Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review, published in November 2014, which members of (a) NHS England's staff and (b) the Clinical Reference Group made up the project team; from where the focus group was drawn; and what the names are of those who sat on that focus group. more like this
star this property tabling member constituency Wells more like this
star this property tabling member printed
Tessa Munt remove filter
star this property uin 213582 more like this
star this property answer
answer
star this property is ministerial correction false remove filter
star this property date of answer less than 2014-11-10more like thismore than 2014-11-10
star this property answer text <p>The Walton Centre NHS Foundation Trust, based in Liverpool, provided the cost information referenced in Section 121 of NHS England's <em>Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review</em>, published on 3 November 2014.</p><p> </p><p> </p><p> </p><p>Two separate consultation (focus group) meetings were held and chaired by Mr Sean Duffy, NHS England’s National Clinical Director for Cancer, involving members of the Radiotherapy Clinical Reference Group (CRG), Adult Neurosurgery CRG, Brain and Central Nervous System CRG, Neurosciences CRG and Stereotactic Radiosurgery CRG to agree key principles and options. Details of the membership of each of the CRGs are set out on the NHS England website at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/ourwork/d-com/spec-serv/crg/" target="_blank">http://www.england.nhs.uk/ourwork/d-com/spec-serv/crg/</a></p><p> </p> more like this
star this property answering member constituency Battersea more like this
unstar this property answering member printed Jane Ellison remove filter
star this property grouped question UIN 213583 more like this
star this property question first answered
less than 2014-11-10T17:16:16.4867715Zmore like thismore than 2014-11-10T17:16:16.4867715Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4089
star this property label Biography information for Tessa Munt more like this
114828
star this property registered interest false more like this
star this property date less than 2014-11-05more like thismore than 2014-11-05
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health remove filter
star this property answering dept sort name Health more like this
star this property hansard heading Radiotherapy more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, with reference to section 121 of NHS England's Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review, published in November 2014, what the names are of those who supplied the data demonstrating (a) the cost effectiveness of treating patients surgically as against treating with stereotactic radiosurgery, (b) the cost of providing surgical treatment and (c) the cost of providing stereotacic radiosurgery. more like this
star this property tabling member constituency Wells more like this
star this property tabling member printed
Tessa Munt remove filter
star this property uin 213583 more like this
star this property answer
answer
star this property is ministerial correction false remove filter
star this property date of answer less than 2014-11-10more like thismore than 2014-11-10
star this property answer text <p>The Walton Centre NHS Foundation Trust, based in Liverpool, provided the cost information referenced in Section 121 of NHS England's <em>Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review</em>, published on 3 November 2014.</p><p> </p><p> </p><p> </p><p>Two separate consultation (focus group) meetings were held and chaired by Mr Sean Duffy, NHS England’s National Clinical Director for Cancer, involving members of the Radiotherapy Clinical Reference Group (CRG), Adult Neurosurgery CRG, Brain and Central Nervous System CRG, Neurosciences CRG and Stereotactic Radiosurgery CRG to agree key principles and options. Details of the membership of each of the CRGs are set out on the NHS England website at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/ourwork/d-com/spec-serv/crg/" target="_blank">http://www.england.nhs.uk/ourwork/d-com/spec-serv/crg/</a></p><p> </p> more like this
star this property answering member constituency Battersea more like this
unstar this property answering member printed Jane Ellison remove filter
star this property grouped question UIN 213582 more like this
star this property question first answered
less than 2014-11-10T17:16:16.174312Zmore like thismore than 2014-11-10T17:16:16.174312Z
star this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4089
star this property label Biography information for Tessa Munt more like this